Mesothelioma
Results
Phase 3
This trial looked at nivolumab to treat mesothelioma that had come back after chemotherapy treatment (relapsed). It was supported by Cancer Research UK.
The trial was open for people to join between 2017 and 2020. The team published the results in 2021.
Recruitment start: 10 May 2017
Recruitment end: 30 March 2020
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Professor Dean Fennell
Cancer Research UK
Southampton Clinical Trials Unit
Stand Up to Cancer (SU2C)
University of Southampton
Mesothelioma UK
This is Cancer Research UK trial number CRUK/16/022.
Last reviewed: 9 December 2021
CRUK internal database number: 14672
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
What to ask your doctor about clinical trials.
Meet and chat to other cancer people affected by cancer.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
